Ch. 13 Sterile and Hazardous Compounding Key Terms

123456789101112131415161718192021222324252627282930
Across
  1. 5. More than one unit of CSP is prepared in a single process for more than one patient and is intended to have uniform characteristics and quality, within specified limits.
  2. 7. A hazardous agent that reduces or prevents the growth of cancer cells.
  3. 9. IV solutions of more than 250 mL that may contain medications, nutrients, or electrolytes.
  4. 10. The ability of two or more base components to combine in solution or with other solutions (such as another IV solution or blood serum) without resulting in physical or chemical property changes to any of them.
  5. 12. The technique of inserting a little air pressure and withdrawing a little fluid into a syringe.
  6. 13. The act of running fluid through IV tubing to flush out small particles and expel air from the tubing before medication administration.
  7. 16. The flow pattern with which cells or tissues respond to the compounded solution.
  8. 17. An IV line that is connected to a catheter inserted in a peripheral vein in a limb rather than in a main blood vein leading ot the heart.
  9. 19. A substance added in multiple-dose containers to inhibit microbial growth and promote a longer shelf-life.
  10. 21. A container of supplies, warning signage, and related materials used to contain the spill of an HD.
  11. 22. The natural flow of the molecules in solutions through semipermeable cell walls.
  12. 23. Drops per milliliter
  13. 25. A specialized practice that compounds and dispenses sterile radioactive pharmaceuticals.
  14. 26. Place the needle tip into the inside of the cap and scoop it up before putting pressure on the cap to secure it.
  15. 27. A small, hermetically sealed sterile container
  16. 29. The concentration of all molecules in a volume of fluid.
  17. 30. (SDV) a container of sterile medication for parenteral administration (e.g., injection or infusion) that is designed for use with a single patient as a single injection/infusion; a single-dose container does not contain a preservative.
Down
  1. 1. (PPN) short-term parenteral nutrition with carbohydrates and/or lipids.
  2. 2. (MDV) a container of sterile medication (water or saline) that contains preservatives used to reconstitute medication powders.
  3. 3. (SVPs) IV solutions of generally 25 to 250 mL, typically administered as an IV piggyback (infusing into the LVP).
  4. 4. An inactive ingredient that is added to the active drug in compounding a tablet, capsule, solution, or topical formulation.
  5. 6. (Log) a record that documents the ingredients, calculations, and compounding process, and any deviations from the master formulation record, which allows for traceability.
  6. 8. A scored area on the neck of an ampule that marks the site where a technician will break the glass to access the ampule’s contents.
  7. 11. A room that is at a lower pressure from adjacent rooms because air is suctioned out into an external filtered exhaust system to protect the compounding personnel from the hazardous agents.
  8. 14. The amount of solution manufacturers add to make up for the loss of water due to evaporation through plastic.
  9. 15. The degree of acidity or alkalinity of a solution; less than 7 is acidic, and more than 7 is alkaline; the pH of blood is 7.4.
  10. 18. A needle that is equipped with a 5-micron (or finer) filter within its core to catch any microscopic glass shards and impurities to prevent them from entering the CSP.
  11. 20. A sterile solution containing a concentration of 0.9% sodium chloride in water.
  12. 24. Administration of IV fluids and/ or medication, commonly expressed in mL per hour.
  13. 28. The pressure required to maintain equilibrium, with no net movement of solvent.